ID   Dakiki
AC   CVCL_3675
SY   DAKIKI; DAKIKI Clone 1
DR   CLO; CLO_0002693
DR   ATCC; TIB-206
DR   BioSample; SAMN03471885
DR   Wikidata; Q54828554
RX   PubMed=6247394;
RX   PubMed=6605913;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: Daikiki; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 9,10
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=6247394; DOI=10.4049/jimmunol.125.1.194;
RA   Steinitz M., Klein G.;
RT   "EBV-transformation of surface IgA-positive human lymphocytes.";
RL   J. Immunol. 125:194-196(1980).
//
RX   PubMed=6605913; DOI=10.1016/0165-2478(83)90049-4;
RA   Ralph P., Saiki O., Maurer D.H., Welte K.;
RT   "IgM and IgG secretion in human B-cell lines regulated by
RT   B-cell-inducing factors (BIF) and phorbol ester.";
RL   Immunol. Lett. 7:17-23(1983).
//